MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by brain atrophy, synaptic loss, extracellular deposition of amyloid-β (Aβ) peptides and intracellular accumulation of neurofibrillary tangles of phosphorylated Tau protein (349–351).